Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
Hyuna Sim(Korea Research Institute of Bioscience and Biotechnology), Janghwan Kim(Biocon (Switzerland))
Cited by 12
Related Papers
Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
|Molecules|2020|22
Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson's Disease Patients
|International Journal of Stem Cells|2019|19